30 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Opportunistic ... HIVAIDS #IDSA #management ... #pharmacology
LOW MOLECULAR WEIGHT HEPARIN (LMWH) DOSING RECOMMENDATIONS (Enoxaparin and Dalteparin):
 - VTE PROPHYLAXIS
 - VTE TREATMENT
Dalteparin): - VTE PROPHYLAXIS ... SYNDROME - BRIDGE THERAPY ... Anticoagulation #VTE #Prophylaxis ... #Pharmacology # ... Management
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
IDSA - Prophylaxis ... First Episode of Opportunistic ... #Opportunistic ... HIVAIDS #IDSA #management ... #pharmacology
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
areas Preferred Therapy ... Patients Preferred Therapy ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Pharmacotherapy for Migraine Prophylaxis 

Who is indicated for migraine prophylaxis? Patients who experience more than 3
indicated for migraine prophylaxis ... contraindications to acute therapy ... #Migraine #Prophylaxis ... Medications #Table #Pharmacology ... #Management #Neurology
IDSA Recommendations for Preventing and Treating Bacterial Enteric Infections in HIV-AIDS
Preventing Bacterial Enteric Illness:
 • Antimicrobial
Antimicrobial prophylaxis ... antimicrobial prophylaxis ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
#Medications #Cardiology ... #Pharmacology # ... Management #Therapy
IDSA Recommendations for Treating Isospora belli Infection in HIV-AIDS
Treating Isospora belli Infection
General Management Considerations:
 • Fluid
Infection General Management ... (Secondary Prophylaxis ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Visceral and Cutaneous Leishmaniasis in HIV-AIDS
Treating Visceral Leishmaniasis - Preferred Therapy:
 •
Chronic Maintenance Therapy ... mm3 Preferred Therapy ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
days) Preferred Therapy ... or Alternative Therapy ... Prevention #Treatment #management ... #opportunistic ... infections #HIVAIDS #pharmacology